| scholarly article | Q13442814 |
| P50 | author | Herbert P. Wiedemann | Q54021613 |
| P2093 | author name string | Lucas Liaudet | |
| François Feihl | |||
| Marie-Denise Schaller | |||
| Mauro Oddo | |||
| Vincent Ribordy | |||
| P2860 | cites work | Attributable risk percent in case-control studies | Q24564145 |
| Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569] | Q24805414 | ||
| Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network | Q27861021 | ||
| Efficacy and safety of recombinant human activated protein C for severe sepsis | Q29547839 | ||
| The acute respiratory distress syndrome | Q29615140 | ||
| The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination | Q29617876 | ||
| Thrombin signalling and protease-activated receptors | Q29619601 | ||
| Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial | Q30788622 | ||
| Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study | Q34271367 | ||
| Treatment of ARDS. | Q34395656 | ||
| The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults | Q34991895 | ||
| Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity | Q37678210 | ||
| Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+,K+-ATPase | Q40398074 | ||
| Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin | Q40526076 | ||
| Protein C and thrombomodulin in human acute lung injury | Q40646976 | ||
| Biological markers of acute lung injury: prognostic and pathogenetic significance | Q41432548 | ||
| Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome | Q43616371 | ||
| Low levels of protein C are associated with poor outcome in severe sepsis | Q43736384 | ||
| Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies | Q44075032 | ||
| Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia | Q44323782 | ||
| Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality | Q44727723 | ||
| Low normal level of protein C or of antithrombin increases risk for recurrent cardiovascular events | Q45130222 | ||
| Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome | Q46156087 | ||
| Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury | Q47934955 | ||
| The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study | Q48935479 | ||
| Time course of hemostatic abnormalities in sepsis and its relation to outcome. | Q64887222 | ||
| Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome | Q68025492 | ||
| Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome | Q68730493 | ||
| The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx | Q69406544 | ||
| Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII | Q69462736 | ||
| Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium | Q69937176 | ||
| ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography | Q70558786 | ||
| Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities | Q71745414 | ||
| Coagulation abnormalities in acute lung injury and sepsis | Q73616516 | ||
| Microvascular responses to sepsis: clinical significance | Q74210483 | ||
| Treating patients with severe sepsis | Q77814988 | ||
| Long-term prognostic value of the hemorheological profile in transmural myocardial infarction survivors: 60-month clinical follow-up | Q78876506 | ||
| Patients with severe sepsis vary markedly in their ability to generate activated protein C | Q80471007 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| cardiac arrest | Q202837 | ||
| hypothermia | Q1036696 | ||
| P304 | page(s) | 1865-1873 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Critical Care Medicine | Q5186605 |
| P1476 | title | From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest | |
| P478 | volume | 34 |
| Q33919345 | 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study |
| Q34022566 | 4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumonia |
| Q26765351 | A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress Syndrome |
| Q39859315 | A national analysis of the relationship between hospital factors and post-cardiac arrest mortality. |
| Q30501707 | A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury |
| Q43922101 | A rapid, safe, and low-cost technique for the induction of mild therapeutic hypothermia in post-cardiac arrest patients |
| Q37678030 | ABO blood type A is associated with increased risk of ARDS in whites following both major trauma and severe sepsis |
| Q35042517 | ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. |
| Q43264829 | Accelerated thrombus lysis in the blood of plasminogen activator inhibitor deficient mice is inhibited by PAI-1 with a very long half-life |
| Q45281844 | Activated protein C attenuates pulmonary coagulopathy in patients with acute respiratory distress syndrome |
| Q38089190 | Activated protein C in the treatment of acute lung injury and acute respiratory distress syndrome |
| Q37218041 | Activated protein C protects against ventilator-induced pulmonary capillary leak |
| Q37445320 | Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study. |
| Q35082828 | Active surface cooling protocol to induce mild therapeutic hypothermia after out-of-hospital cardiac arrest: a retrospective before-and-after comparison in a single hospital |
| Q91794523 | Acute Respiratory Distress Syndrome Phenotypes |
| Q35097126 | Acute lung injury: epidemiology, pathogenesis, and treatment |
| Q35412409 | Acute respiratory distress syndrome: A clinical review |
| Q28387778 | Alcohol and inflammatory responses: highlights of the 2015 Alcohol and Immunology Research Interest Group (AIRIG) meeting |
| Q35794087 | Anti-inflammatory and anticoagulative effects of paeonol on LPS-induced acute lung injury in rats |
| Q92191206 | Antithrombin plus alpha-1 protease inhibitor does not affect coagulation and inflammation in two murine models of acute lung injury |
| Q40388238 | Asiatic Acid Inhibits Lipopolysaccharide-Induced Acute Lung Injury in Mice |
| Q35755770 | Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography. |
| Q57060431 | Association Between Therapeutic Hypothermia and Outcomes in Patients with Non-shockable Out-of-Hospital Cardiac Arrest Developed After Emergency Medical Service Arrival (SOS-KANTO 2012 Analysis Report) |
| Q57314319 | Association between urokinase haplotypes and outcome from infection-associated acute lung injury |
| Q33752962 | Automated peritoneal lavage: an extremely rapid and safe way to induce hypothermia in post-resuscitation patients |
| Q36351797 | Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo |
| Q37925155 | Bench-to-bedside review: Ventilation-induced renal injury through systemic mediator release--just theory or a causal relationship? |
| Q33868624 | Beyond mortality: future clinical research in acute lung injury |
| Q36578229 | Bioinformatics insights into acute lung injury/acute respiratory distress syndrome |
| Q41431807 | Biomarkers for patients with trauma associated acute respiratory distress syndrome |
| Q26744577 | Biomarkers in Pediatric ARDS: Future Directions |
| Q35100674 | Biomarkers in acute lung injury--marking forward progress |
| Q43131878 | Biomarkers in acute lung injury: are we making progress? |
| Q37858108 | Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury |
| Q38215937 | Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care |
| Q34094906 | Biomarkers of acute lung injury: worth their salt? |
| Q36749015 | Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury |
| Q35567004 | Blood transfusion during cardiac surgery is associated with inflammation and coagulation in the lung: a case control study. |
| Q51866728 | Brain diffusivity in infants with hypoxic-ischemic encephalopathy following whole body hypothermia: preliminary results. |
| Q23909719 | Brain resuscitation in the drowning victim |
| Q35860746 | Cardiac Arrest Disrupts Caspase-1 and Patterns of Inflammatory Mediators Differently in Skin and Muscle Following Localized Tissue Injury in Rats: Insights from Data-Driven Modeling |
| Q37277715 | Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury |
| Q34130693 | Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. |
| Q48418736 | Clinical evolution after a non-reactive hypothermic EEG following cardiac arrest |
| Q36633471 | Clinical review: Early treatment of acute lung injury--paradigm shift toward prevention and treatment prior to respiratory failure |
| Q31135319 | Clinical review: Prognostic value of magnetic resonance imaging in acute brain injury and coma |
| Q36465364 | Clinical review: beyond immediate survival from resuscitation-long-term outcome considerations after cardiac arrest |
| Q38026809 | Coagulation cascade proteinases in lung injury and fibrosis |
| Q99636156 | Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system |
| Q42415612 | Coma due to cardiac arrest: prognosis and contemporary treatment |
| Q36577499 | Comparison of whole-body cooling and selective head cooling on changes in urinary 8-hydroxy-2-deoxyguanosine levels in patients with global brain ischemia undergoing mild hypothermia therapy. |
| Q57455432 | Complex Legacy of the Target Temperature Management Trial |
| Q37767304 | Contemporary practices in postcardiac arrest syndrome: the role of mild therapeutic hypothermia |
| Q35219875 | Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice |
| Q35672843 | Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies |
| Q35865114 | Earlier Hypothermia Attainment is Associated with Improved Outcomes after Cardiac Arrest |
| Q46526744 | Early EEG monitoring for detecting postanoxic status epilepticus during therapeutic hypothermia: a pilot study |
| Q47149095 | Early identification of patients at risk for acute respiratory distress syndrome among severe pneumonia: a retrospective cohort study. |
| Q34380703 | Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study |
| Q21195028 | Efficacy of and tolerance to mild induced hypothermia after out-of-hospital cardiac arrest using an endovascular cooling system |
| Q33595107 | Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury |
| Q37140992 | Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines? |
| Q38647809 | Factors Influencing the Quality of Standardized Treatment for Patients with Post-Cardiac Arrest Syndrome |
| Q42425466 | Favorable Outcome and Survival Using a Hypothermia Protocol After Successful Cardiopulmonary Resuscitation |
| Q37970138 | Genetic predisposition to respiratory infection and sepsis |
| Q34113137 | High tidal volume mechanical ventilation-induced lung injury in rats is greater after acid instillation than after sepsis-induced acute lung injury, but does not increase systemic inflammation: an experimental study |
| Q33433019 | Higher pulmonary dead space may predict prolonged mechanical ventilation after cardiac surgery |
| Q33672443 | Hyaluronic Acid binding protein 2 is a novel regulator of vascular integrity |
| Q26825499 | Hypothermia therapy: neurological and cardiac benefits |
| Q50084516 | Hypothermie thérapeutique après arrêt cardio-respiratoire en 2017 – revue pour le praticien |
| Q37378563 | Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure |
| Q36358254 | Impact of obesity on outcomes for patients hospitalised with pneumonia |
| Q37151959 | Implementation of a post-arrest care team: understanding the nuances of a team-based intervention |
| Q84471506 | Improved prognosis after using mild hypothermia to treat cardiorespiratory arrest due to a cardiac cause: comparison with a control group |
| Q38426188 | Improving neurological outcome after cardiac arrest: Therapeutic hypothermia the best treatment |
| Q34005299 | Incidence of re-arrest and critical events during prolonged transport of post-cardiac arrest patients |
| Q37186092 | Induced hypothermia and fever control for prevention and treatment of neurological injuries |
| Q62484200 | Induction of Therapeutic Hypothermia by Paramedics After Resuscitation From Out-of-Hospital Ventricular Fibrillation Cardiac Arrest |
| Q33919295 | Inhaled activated protein C protects mice from ventilator-induced lung injury |
| Q39971820 | Inhaled activated protein C: a novel therapy for acute lung injury? |
| Q35159761 | Inhibition of neutrophil apoptosis by PAI-1. |
| Q46317704 | Intensive care unit mortality after cardiac arrest: the relative contribution of shock and brain injury in a large cohort |
| Q31144732 | Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest - an analysis of the TTM trial data |
| Q64110092 | Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest: an analysis of the TTH48 trial |
| Q36793764 | Kinetics and Role of Plasma Matrix Metalloproteinase-9 Expression in Acute Lung Injury and the Acute Respiratory Distress Syndrome |
| Q58037992 | Kurzdarstellung |
| Q43191962 | Linking genetics to ARDS pathogenesis: the role of the platelet. |
| Q36868476 | Long-Term Effects of Induced Hypothermia on Local and Systemic Inflammation - Results from a Porcine Long-Term Trauma Model |
| Q36220113 | Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury |
| Q37053023 | Markers of inflammation and coagulation may be modulated by enteral feeding strategy |
| Q61671425 | Mejora del pronóstico tras parada cardiorrespiratoria de causa cardiaca mediante el empleo de hipotermia moderada: comparación con un grupo control |
| Q37191014 | Mesenchymal stem cells in acute lung injury: are they ready for translational medicine? |
| Q27318057 | Microarray meta-analysis identifies acute lung injury biomarkers in donor lungs that predict development of primary graft failure in recipients |
| Q41857085 | Mild induced hypothermia after out-of-hospital cardiac arrest: persisting doubts about patient safety |
| Q28073009 | Mild therapeutic hypothermia in patients resuscitated from out-of-hospital cardiac arrest: A meta-analysis of randomized controlled trials |
| Q36787279 | Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls |
| Q36827337 | Moderately lower temperatures greatly extend the lifespan of Brachionus manjavacas (Rotifera): Thermodynamics or gene regulation? |
| Q38006576 | Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigations |
| Q37138889 | Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury |
| Q42275428 | Network clusters analysis based on protein-protein interaction network constructed in phosgene-induced acute lung injury |
| Q35730432 | Omega-3 fatty acids in critical illness |
| Q37613099 | Out-of-hospital therapeutic hypothermia in cardiac arrest victims |
| Q48265143 | Outcomes of mild therapeutic hypothermia after in-hospital cardiac arrest |
| Q37801119 | Part 12: Education, implementation, and teams: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations |
| Q37801125 | Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. |
| Q36312498 | Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials |
| Q43179135 | Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. |
| Q36662909 | Pharmacotherapy considerations in advanced cardiac life support |
| Q90368607 | Phenotypes in acute respiratory distress syndrome: moving towards precision medicine |
| Q36751000 | Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS. |
| Q33994636 | Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis |
| Q33685205 | Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury |
| Q47738050 | Plasminogen Activator Inhibitor-1 Is Critical in Alcohol-Enhanced Acute Lung Injury in Mice. |
| Q51703244 | Plasminogen activator inhibitor-1 regulates LPS induced inflammation in rat macrophages through autophagy activation. |
| Q38945452 | Plasminogen activator inhibitor-1 regulates LPS-induced TLR4/MD-2 pathway activation and inflammation in alveolar macrophages |
| Q35119519 | Plasminogen activator inhibitor-type I gene deficient mice show reduced influx of neutrophils in ventilator-induced lung injury |
| Q42190521 | Platelets enhance endothelial adhesiveness in high tidal volume ventilation |
| Q36237204 | Platelets in the pathogenesis of acute respiratory distress syndrome |
| Q92228726 | Platelets: Lone Rangers of Inflammatory Signaling in the Lung |
| Q38618065 | Point-of-care washing of allogeneic red blood cells for the prevention of transfusion-related respiratory complications (WAR-PRC): a protocol for a multicenter randomised clinical trial in patients undergoing cardiac surgery |
| Q40002665 | Post-cardiac arrest therapeutic hypothermia: overcoming the barrier of workplace culture and other implementation lessons |
| Q42860753 | Postexposure aerosolized heparin reduces lung injury in chlorine-exposed mice. |
| Q37793780 | Practical Implementation of Therapeutic Hypothermia After Cardiac Arrest |
| Q35801043 | Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. |
| Q37486406 | Predictive modeling and inflammatory biomarkers in rats with lung contusion and gastric aspiration |
| Q85217823 | Prehospital initiation of mild therapeutic hypothermia for out-of-hospital cardiac arrest (OHCA): where are we now? |
| Q36497048 | Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? |
| Q33512670 | Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury |
| Q35946855 | Prognostic factors in the acute respiratory distress syndrome |
| Q45018242 | Progression of auditory discrimination based on neural decoding predicts awakening from coma |
| Q39787675 | Protective effect of resveratrol on acute lung injury induced by lipopolysaccharide in mice |
| Q37494702 | Protective mechanisms of activated protein C in severe inflammatory disorders. |
| Q36619643 | Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk |
| Q39107058 | Protein biomarkers associated with primary graft dysfunction following lung transplantation |
| Q34302302 | Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors |
| Q38887825 | Proteomic study of acute respiratory distress syndrome: current knowledge and implications for drug development |
| Q38320363 | Pulmonary vascular dysfunction in ARDS. |
| Q30224587 | RECOVER evidence and knowledge gap analysis on veterinary CPR. Part 7: Clinical guidelines |
| Q36889970 | Randomized clinical trial of activated protein C for the treatment of acute lung injury |
| Q36342998 | Recent insight into potential acute respiratory distress syndrome |
| Q51732708 | Recombinant Human Soluble Thrombomodulin Contributes to Reduced Mortality in Sepsis Patients with Severe Respiratory Failure: A Retrospective Observational Study Using a Multicenter Dataset. |
| Q35121618 | Recombinant human activated protein C in the treatment of acute respiratory distress syndrome: a randomized clinical trial. |
| Q64064108 | Relation between Red Cell Distribution Width and Mortality in Critically Ill Patients with Acute Respiratory Distress Syndrome |
| Q30441965 | Robust discrimination between EEG responses to categories of environmental sounds in early coma. |
| Q35694993 | Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury |
| Q58761308 | Rosiglitazone Reduces Apoptosis and Inflammation in Lipopolysaccharide-Induced Human Umbilical Vein Endothelial Cells |
| Q35787544 | Short- and long-latency somatosensory neuronal responses reveal selective brain injury and effect of hypothermia in global hypoxic ischemia |
| Q36939957 | Shorter time to target temperature is associated with poor neurologic outcome in post-arrest patients treated with targeted temperature management. |
| Q37412874 | Similar long-term survival of consecutive in-hospital and out-of-hospital cardiac arrest patients treated with targeted temperature management |
| Q52686665 | Stability of ARDS subphenotypes over time in two randomised controlled trials. |
| Q43480378 | SuPAR and PAI-1 in critically ill, mechanically ventilated patients |
| Q30826105 | Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials |
| Q37830387 | Surface cooling after cardiac arrest: effectiveness, skin safety, and adverse events in routine clinical practice. |
| Q46494590 | Surface cooling for rapid induction of mild hypothermia after cardiac arrest: design determines efficacy |
| Q37791168 | Targeted Temperature Management for Comatose Survivors of Cardiac Arrest |
| Q27016107 | Targeted temperature management after out-of-hospital cardiac arrest: who, when, why, and how? |
| Q33599073 | The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilization |
| Q34299206 | The Esophageal Pressure-Guided Ventilation 2 (EPVent2) trial protocol: a multicentre, randomised clinical trial of mechanical ventilation guided by transpulmonary pressure |
| Q28075868 | The Role of Targeted Temperature Management in Adult Patients Resuscitated from Nonshockable Cardiac Arrests: An Updated Systematic Review and Meta-Analysis |
| Q34130717 | The association between BMI and plasma cytokine levels in patients with acute lung injury |
| Q87361883 | The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial |
| Q44289437 | The bispectral index and suppression ratio are very early predictors of neurological outcome during therapeutic hypothermia after cardiac arrest |
| Q33639915 | The effect of hypothermia "dose" on vasopressor requirements and outcome after cardiac arrest |
| Q35048082 | The effect of therapeutic hypothermia on drug metabolism and response: cellular mechanisms to organ function |
| Q89968892 | The influence of therapeutic hypothermia on the outcomes of cardiac arrest survivors: a retrospective cohort study |
| Q34438052 | The practice of therapeutic hypothermia after cardiac arrest in France: a national survey |
| Q37082973 | The protein C pathway: implications for the design of the RESPOND study |
| Q46001232 | Therapeutic Hypothermia After Resuscitation From a Non-Shockable Rhythm Improves Outcomes in a Regionalized System of Cardiac Arrest Care. |
| Q37823317 | Therapeutic applications of hypothermia in cerebral ischaemia |
| Q34388826 | Therapeutic hypothermia |
| Q45030947 | Therapeutic hypothermia after cardiac arrest - implementation in UK intensive care units |
| Q35740238 | Therapeutic hypothermia and prevention of acute kidney injury: a meta-analysis of randomized controlled trials |
| Q84042493 | Therapeutic hypothermia and reliability of somatosensory evoked potentials in predicting outcome after cardiopulmonary arrest |
| Q83331731 | Therapeutic hypothermia for cardiac arrest: a practical approach |
| Q37310540 | Therapeutic hypothermia for cardiac arrest: a practical approach. |
| Q36458121 | Therapeutic hypothermia for out-of-hospital cardiac arrest: An analysis comparing cooled and not cooled groups at a Canadian center |
| Q37837114 | Therapeutic hypothermia for out-of-hospital cardiac arrest: an update for neurosurgeons |
| Q34348140 | Therapeutic hypothermia is associated with a decrease in urine output in acute stroke patients |
| Q41983436 | Therapeutic hypothermia protocol in a community emergency department |
| Q36902470 | Therapeutic hypothermia: is it effective for non-VF/VT cardiac arrest? |
| Q37852747 | Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome |
| Q39274823 | Tissue plasminogen activator attenuates ventilator-induced lung injury in rats |
| Q37714536 | Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study |
| Q36769694 | Update in critical care 2006. |
| Q46412139 | Use of a standardized order set for achieving target temperature in the implementation of therapeutic hypothermia after cardiac arrest: a feasibility study |
| Q37636646 | Use of hypothermia in the intensive care unit |
| Q33808300 | Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury |
| Q35474984 | Using vascular closure devices following out-of-hospital cardiac arrest? |
| Q38160168 | What is the clinical significance of pulmonary hypertension in acute respiratory distress syndrome? A review |
| Q54089883 | [Mild therapeutic hypothermia: Improved survival after resuscitation]. |
| Q84011474 | [Post-cardiac arrest syndrome after general anesthesia: role of therapeutic hypothermia and remifentanil] |
| Q82819265 | [Therapeutic hypothermia after cardiopulmonary resuscitation - pro and con] |
Search more.